Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised King in connection with the acquisition of Peltarion AB
Mandate

Vinge has advised King in connection with the acquisition of Peltarion AB

June 15, 2022 Employment and Benefits M&A Corporate Tax Banking and Finance IT, Telecommunications and Outsourcing Commercial Agreements

Vinge has advised King in connection with the acquisition of the operational AI platform provider Peltarion AB.  

Vinge’s team consisted primarily of Ulrich Ziche, Isabelle Wållgren and Robin Fagerström (M&A), Åsa Gotthardsson, Ebba Svenburg and Emil Lindwall (Employment), Alexander Lindberg (IP/IT/GDPR), Isabell Nielsen and Mario Saad (Commercial Agreements), Axel Jansson and Nour Makie (Banking and Finance), Maria Schultzberg (Tax) as well as Julia Hagelberg and Sara Dahlros Sköld (project assistants).

For more information about the transaction please see the client’s press release

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026